COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,458,076 | +4.9% | 109,982 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $2,342,281 | +95153.4% | 108,994 | +6.4% | 0.00% | 0.0% |
| Q1 2023 | $2,459 | +11.2% | 102,481 | +7.5% | 0.00% | 0.0% |
| Q4 2022 | $2,211 | -99.9% | 95,296 | +0.2% | 0.00% | +50.0% |
| Q3 2022 | $1,524,000 | -7.9% | 95,107 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $1,654,000 | -15.6% | 93,357 | -3.0% | 0.00% | -33.3% |
| Q1 2022 | $1,959,000 | +15.6% | 96,224 | +6.1% | 0.00% | +50.0% |
| Q4 2021 | $1,695,000 | -4.1% | 90,715 | +1.3% | 0.00% | 0.0% |
| Q3 2021 | $1,768,000 | -26.0% | 89,556 | -11.4% | 0.00% | -33.3% |
| Q2 2021 | $2,389,000 | -3.4% | 101,051 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $2,474,000 | +159.1% | 104,387 | +118.9% | 0.00% | +200.0% |
| Q4 2020 | $955,000 | -4.0% | 47,695 | -0.2% | 0.00% | -50.0% |
| Q3 2020 | $995,000 | +1.0% | 47,776 | -15.1% | 0.00% | 0.0% |
| Q2 2020 | $985,000 | +27.4% | 56,299 | +19.0% | 0.00% | 0.0% |
| Q1 2020 | $773,000 | -17.6% | 47,309 | +3.8% | 0.00% | 0.0% |
| Q4 2019 | $938,000 | +83.2% | 45,563 | +2.1% | 0.00% | +100.0% |
| Q3 2019 | $512,000 | -11.3% | 44,620 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $577,000 | -1.0% | 43,914 | +14.1% | 0.00% | 0.0% |
| Q1 2019 | $583,000 | -13.0% | 38,482 | -1.4% | 0.00% | 0.0% |
| Q4 2018 | $670,000 | +71.4% | 39,018 | +47.0% | 0.00% | 0.0% |
| Q3 2018 | $391,000 | -42.2% | 26,541 | -6.4% | 0.00% | 0.0% |
| Q2 2018 | $676,000 | +4.0% | 28,341 | +11.5% | 0.00% | 0.0% |
| Q1 2018 | $650,000 | +39.8% | 25,425 | +1.0% | 0.00% | 0.0% |
| Q4 2017 | $465,000 | +60.3% | 25,183 | -8.9% | 0.00% | 0.0% |
| Q3 2017 | $290,000 | -15.5% | 27,633 | +0.8% | 0.00% | 0.0% |
| Q2 2017 | $343,000 | +92.7% | 27,403 | +55.0% | 0.00% | – |
| Q1 2017 | $178,000 | -24.3% | 17,679 | +17.0% | 0.00% | -100.0% |
| Q4 2016 | $235,000 | -0.4% | 15,111 | +23.4% | 0.00% | 0.0% |
| Q3 2016 | $236,000 | +65.0% | 12,250 | +1.7% | 0.00% | – |
| Q2 2016 | $143,000 | – | 12,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |